SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (17905)1/19/1999 2:07:00 PM
From: VLAD  Respond to of 23519
 
martin,

You just don't get it. Any Vivus long who has been holding this BODV for 12 + months knows that it is in the best interest for him/her to EXPECT THE WORST! Leland has a habit of a perfect track record of disappointments over the past 12 months.

I'm not saying we can't get lucky this time, but I'm not getting my hopes up.

At least nobody can accuse me of being a Vivus cheer leader.

PS Still believe in the product but can't stand the management. Still keeping the powder dry for that "share holder movement".



To: Mkilloran who wrote (17905)1/19/1999 2:24:00 PM
From: Greg22  Read Replies (2) | Respond to of 23519
 
VLAD, I do not think you are giving the Viagra/Muse story enough time to play itself out. These things take time and require patients.
I realize there is a cost to waiting, but this cost does not outweigh potential rewards. I think Leland is smart to wait, and is doing a great job considering the circumstances.

As far as Q4 goes, connect the dots.

Q2 = (-.63)
Q3 = (-.02)
Q4 = (?)

I see +0.01 to +0.03. No way less than 0 after restructuring.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News